Editing Mesothelioma Treatment Centers (section)

== Which Treatment Centers Lead in Mesothelioma Patient Outcomes? ==

=== International Mesothelioma Program at Brigham and Women's Hospital ===

The International Mesothelioma Program at Brigham and Women's Hospital in Boston leads globally with approximately '''180 mesothelioma patients treated annually'''. The program achieves remarkable outcomes including '''69.8 months median survival''' for epithelioid histology patients with T1 disease and a '''54.1% five-year survival rate''' for this favorable population. Under Dr. Raphael Bueno's leadership as Chief of the Division of Thoracic Surgery, the center pioneered numerous surgical innovations including the world's first iVATS (image-guided video-assisted thoracic surgery) procedure for mesothelioma.

'''Contact Information:'''
* Location: 75 Francis Street, Boston, MA 02115
* Phone: 617-732-6824
* Leadership: Dr. Raphael Bueno, Chief of Division of Thoracic Surgery

The program's extended pleurectomy/decortication approach has achieved '''zero 30-day and 90-day mortality rates''' while delivering 38.1 months median survival—significantly exceeding the 24 months achieved with extrapleural pneumonectomy.<ref>[https://mesothelioma.net/mesothelioma-surgery/ Mesothelioma Surgery Options], Mesothelioma.net</ref> This lung-sparing approach now represents the standard of care at leading institutions. Veterans treated at this center can simultaneously pursue VA disability benefits alongside civilian compensation claims.<ref>[https://dandell.com/mesothelioma-veterans/ Veterans & Mesothelioma Claims], Danziger & De Llano</ref>

=== Memorial Sloan Kettering Cancer Center ===

Memorial Sloan Kettering Cancer Center in New York maintains one of the nation's '''largest mesothelioma databases with over 1,000 patients treated''', positioning itself at the forefront of immunotherapy and cellular therapy research. Co-directed by Dr. Prasad S. Adusumilli and Dr. Marjorie G. Zauderer, the program achieves '''23.9 months median overall survival''' in pioneering CAR-T cell therapy plus pembrolizumab combination trials. U.S. News & World Report ranks Memorial Sloan Kettering #2 nationally for cancer care (2026-2027 edition).

'''Contact Information:'''
* Location: 1275 York Avenue, New York, NY 10065
* Phone: 212-639-8876
* Leadership: Dr. Prasad S. Adusumilli and Dr. Marjorie G. Zauderer, Co-Directors

The center's comprehensive pleural and peritoneal mesothelioma programs integrate cutting-edge immunotherapy protocols with surgical expertise.<ref>[https://mesotheliomaattorney.com/mesothelioma/types/pleural/ Pleural Mesothelioma Guide], MesotheliomaAttorney.com</ref> Patients seeking legal representation in New York can coordinate medical treatment with compensation claims through experienced attorneys familiar with the state's court system.<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-lawyer/new-york/ New York Mesothelioma Attorneys], Mesothelioma Lawyer Center</ref>

=== MD Anderson Cancer Center ===

MD Anderson Cancer Center in Houston, ranked '''#1 nationally for cancer care for ten consecutive years''', operates a comprehensive mesothelioma program treating hundreds of patients annually through its 30+ member thoracic oncology team. Under Dr. Anne Tsao's direction, MD Anderson has become a leader in immunotherapy research, currently conducting '''16 active mesothelioma clinical trials''' including the pivotal DREAM3R study investigating durvalumab combinations.

'''Contact Information:'''
* Location: 1515 Holcombe Boulevard, Houston, TX 77030
* Phone: 713-792-6161
* Financial Specialists: 713-745-9998
* Leadership: Dr. Anne Tsao, Director of Mesothelioma Program

{| style="width:100%; background:#d4edda; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"
|-
| style="padding:15px; color:#155724;" | '''✓ Texas Patients Benefit:''' MD Anderson's Houston location provides Texas residents with world-class care close to home. Houston mesothelioma attorneys at Danziger & De Llano work closely with patients receiving treatment at MD Anderson to ensure medical care and legal claims proceed in coordination.<ref>[https://dandell.com/mesothelioma-lawyer/texas/houston/ Houston Mesothelioma Lawyer], Danziger & De Llano</ref>
|}

=== Additional NCI-Designated Comprehensive Cancer Centers ===

Several other National Cancer Institute-designated centers operate specialized mesothelioma programs with documented excellence:

'''Mayo Clinic''' (Rochester, Phoenix, Jacksonville): Treats '''100+ mesothelioma patients annually''' across three locations, conducting 33 active mesothelioma research studies while developing novel immunotherapy combinations. The multidisciplinary approach integrates thoracic surgery, medical oncology, and radiation therapy for personalized treatment planning.

'''UCLA Jonsson Comprehensive Cancer Center''': Dr. Robert Cameron revolutionized lung-sparing surgical approaches and established the West Los Angeles VA Mesothelioma Program serving veterans nationwide. The program demonstrates particular expertise in sarcomatoid mesothelioma, the most aggressive cell type, and offers telemedicine consultations for patients unable to travel. UCLA's approach to epithelioid mesothelioma incorporates the latest surgical innovations with immunotherapy protocols.<ref>[https://mesotheliomaattorney.com/mesothelioma/types/epithelioid/ Epithelioid Mesothelioma Guide], MesotheliomaAttorney.com</ref>

'''University of Pennsylvania Abramson Cancer Center''': Pioneers in CAR-T cell therapy and photodynamic therapy for mesothelioma, achieving '''31.7-36 months median survival''' with light-activated treatment approaches. The center's proximity to Philadelphia's industrial history serves numerous patients with Pennsylvania asbestos exposure claims.<ref>[https://www.mesotheliomalawyercenter.org/mesothelioma-lawyer/pennsylvania/ Pennsylvania Mesothelioma Attorneys], Mesothelioma Lawyer Center</ref>

'''H. Lee Moffitt Cancer Center''' (Tampa): Florida's first NCI comprehensive cancer center treats hundreds of mesothelioma patients annually, achieving '''17.3% five-year survival'''—2.5 times the national average—through integrated multimodal treatment protocols combining surgery, chemotherapy, and radiation therapy.<ref>[https://mesotheliomaattorney.com/mesothelioma/treatment/ Mesothelioma Treatment Options], MesotheliomaAttorney.com</ref>

----